Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral health care and antiseptic mouth rinse for hospitalized patients with COVID-19
IRCT20200527047581N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of chlorhexidine and povidone-iodine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Kashan University of Medical Sciences. Primary endpoints: survival rate, clinical outcome and 1 more. Started Sep 2020; status: completed.
02
Drugs
chlorhexidinepovidone-iodine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200527047581N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200527047581N1.